RBC Capital analyst Leonid Timashev lowered the firm’s price target on Pyxis Oncology (PYXS) to $8 from $10 and keeps an Outperform rating on the shares. The company’s pipeline update to prioritize ...
MOSCOW. Dec 16 (Interfax) - Norilsk Nickel has finalized its strategy of cooperation with China taking into account the need to maintain the tax base and jobs in Russia, Nornickel CEO Vladimir Potanin ...
13, according to a report from RBC Capital Markets analyst Dan Perlin. “These changes are in line with management's price to value strategy, as well as enables PayPal to better show the BNPL value ...